Insider Transactions in Q2 2023 at Bei Gene, Ltd. (BGNE)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 26
2023
|
Xiaobin Wu President, COO & GM China |
SELL
Open market or private sale
|
Direct |
1,495
-100.0%
|
$272,090
$182.37 P/Share
|
|
Jun 26
2023
|
Lai Wang Global Head of R&D |
SELL
Open market or private sale
|
Direct |
1,108
-99.77%
|
$201,656
$182.53 P/Share
|
|
Jun 23
2023
|
Corazon (Corsee) D. Sanders Director |
SELL
Open market or private sale
|
Direct |
578
-58.65%
|
$104,618
$181.7 P/Share
|
|
Jun 23
2023
|
Julia Aijun Wang Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
840
-100.0%
|
$152,880
$182.85 P/Share
|
|
Jun 20
2023
|
Xiaobin Wu President, COO & GM China |
SELL
Open market or private sale
|
Direct |
1,753
-100.0%
|
$336,576
$192.44 P/Share
|
|
Jun 20
2023
|
Julia Aijun Wang Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
190
-100.0%
|
$36,480
$192.54 P/Share
|
|
Jun 20
2023
|
Lai Wang Global Head of R&D |
SELL
Open market or private sale
|
Direct |
1,325
-100.0%
|
$254,400
$192.42 P/Share
|
|
Jun 15
2023
|
John Oyler Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
355,641
+15.28%
|
-
|
|
Jun 15
2023
|
Xiaodong Wang Director |
BUY
Grant, award, or other acquisition
|
Direct |
86,216
+1.53%
|
-
|
|
Jun 15
2023
|
Xiaobin Wu President, COO & GM China |
BUY
Grant, award, or other acquisition
|
Direct |
200,447
+16.25%
|
-
|
|
Jun 15
2023
|
Julia Aijun Wang Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
107,770
+23.95%
|
-
|
|
Jun 15
2023
|
Margaret Dugan Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,922
+30.38%
|
-
|
|
Jun 15
2023
|
Corazon (Corsee) D. Sanders Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,922
+25.67%
|
-
|
|
Jun 15
2023
|
Thomas Malley Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,922
+21.67%
|
-
|
|
Jun 15
2023
|
Alessandro Riva Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,922
+30.38%
|
-
|
|
Jun 15
2023
|
Chan Henry Lee SVP, General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
65,585
+26.53%
|
-
|
|
Jun 15
2023
|
Donald W. Glazer Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,922
+0.46%
|
-
|
|
Jun 15
2023
|
Anthony C Hooper Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,922
+25.67%
|
-
|
|
Jun 15
2023
|
Lai Wang Global Head of R&D |
BUY
Grant, award, or other acquisition
|
Direct |
133,627
+7.64%
|
-
|
|
Jun 15
2023
|
Baker Bros. Advisors LP |
BUY
Grant, award, or other acquisition
|
Indirect |
51,688
+21.67%
|
-
|
|
Jun 15
2023
|
Qingqing Yi Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,922
+30.38%
|
-
|
|
Jun 14
2023
|
Hhlr Advisors, Ltd. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
273,728
-0.19%
|
$56,661,696
$207.72 P/Share
|
|
Jun 13
2023
|
Hhlr Advisors, Ltd. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
924,400
-0.32%
|
$156,223,600
$169.94 P/Share
|
|
Jun 12
2023
|
Hhlr Advisors, Ltd. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
1,250,212
-0.43%
|
$215,036,464
$172.37 P/Share
|
|
Jun 09
2023
|
Hhlr Advisors, Ltd. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
542,652
-0.19%
|
$93,878,796
$173.69 P/Share
|
|
Jun 08
2023
|
Hhlr Advisors, Ltd. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
1,163,825
-0.79%
|
$253,713,850
$218.14 P/Share
|
|
Jun 07
2023
|
Xiaobin Wu President, COO & GM China |
SELL
Open market or private sale
|
Direct |
3,291
-51.65%
|
$737,184
$224.67 P/Share
|
|
Jun 07
2023
|
Lai Wang Global Head of R&D |
SELL
Open market or private sale
|
Direct |
462
-51.6%
|
$103,488
$224.67 P/Share
|
|
May 08
2023
|
Xiaobin Wu President, COO & GM China |
SELL
Open market or private sale
|
Direct |
7,000
-100.0%
|
$1,771,000
$253.72 P/Share
|